OSTEOSARCOMA (OS) is the most common pediatric bone malignancy that occurs primarily in adolescents and young adults in the world [1] [2] [3] [4] [5] . The exact mechanism of development of OS carcinogenesis still remains poorly understood. Patients with localized OS at presentation have a 60-80% rate of long-term survival, while metastatic disease carries a poorer prognosis [6, 7] . It is estimated that the annual incidence rate for individuals less than 20 years old is 8.7 per million children, and account for ~ 6% of childhood cancer [8, 9] . Several studies suggest that multiple factors such as genetic mutations and environment factors could affect the OS pathogenesis. However, the genetic factors could play key roles in the pathogenesis of OS [9] [10] [11] [12] [13] [14] [15] 
gene for influencing the susceptibility to OS [16] [17] [18] [19] [20] [21] . The single nucleotide polymorphisms (SNPs) in MDM2 gene (such as rs2279744 (T309G) and rs1690916) have been analyzed the potential association with OS susceptibility and might have influences on the development of OS [16] [17] [18] [19] . However, the association of MDM2 genetic variants with OS occurrence is not well understood. Up to now, the potential association of c.44C>T and c.1002T>C genetic variants in MDM2 gene with the susceptibility to OS have not been reported. Thus, the objective of this study aimed to investigate the distribution of MDM2 c.44C>T and c.1002T>C genetic variants and to assess whether these genetic variants influence on OS susceptibility in Chinese Han population.
Materials and Methods

Study population
A total of 415 diagnosed OS patients (aged 10-68 years old) and 431 healthy subjects (aged 12-67 years old) who had no history of OS as controls were recruited from the Second Xiangya Hospital Affiliated with Central South University between January 2004 and December 2012. All subjects were unrelated Chinese with Han nationality and lived in Changsha city of China. The cancer-free controls were matched with OS patients with regards to gender, age and residence area (urban or rural). Table 1 shows the general characteristics, including gender, sex, tumor location, and metastasis. The written informed consent was obtained from each participant. The protocol of this study was approved by the Ethics Committee of Second Xiangya Hospital Affiliated with Central South University.
DNA extraction and PCR amplification
Gnomic DNA was extracted from peripheral venous blood using the blood genomic DNA miniprep kit (Axygen Biosciences) according to the manufacturer's instructions. Based on the mRNA sequences (GenBank ID: NM_002392.4) and DNA sequences (GenBank ID: NG_016708.1) of the human MDM2 gene, two pair of primers were designed by the Primer Premier 5.0 software (PREMIER Biosoft International, Palo Alto, CA). Table 2 shows the primers sequences, annealing temperature, fragment sizes and region. The polymerase chain reaction (PCR) reaction was performed in a total volume of 20 µL solution containing 50ng template DNA, 1×buffer (Tris-HCl 100 mmol/L, pH 8.3; KCl 500 mmol/L), 0.25 µmol/L primers, 2.0 mmol/L MgCl 2 , 0.25 mmol/L dNTPs, and 0.5U Taq DNA polymerase (Promega, Madison, WI, USA). The PCR cycle conditions were as followed: an initial 94°C for 5 minutes, then followed by 34 cycles of 94°C for 30 seconds, annealing at the corresponding temperature (given in Table 2 ) for 30 seconds and 72°C for 30 seconds, and a final extension at 72°C for 5 minutes. The PCR products were separated by electrophoresis in 2.0% agarose gel containing ethidium-bromide and observed under UV light.
Genotyping of MDM2 genetic variants
The c.44C>T genetic variant in MDM2 gene was genotyped by the created restriction site-PCR (CRS-PCR) method with one of the primers containing a nucleotide mismatch, which enables the use of restriction enzymes for discriminating sequence variations [22] [23] [24] [25] [26] . The genotyping of c.1002T>C genetic variant in MDM2 gene was detected by the PCR-restriction fragment length polymorphism (PCR-RFLP) method. According to the supplier's manual, aliquots of 5 μL PCR products were digested with 2U selected restriction enzyme (MBI Fermentas, St. Leon-Rot, Germany, shown in Table 2 ) at 37°C for 10 hours. The digested products were separated by 2.5% agarose gel electrophoresis containing ethidium-bromide and observed under UV light. To confirm the genotyping results from CRS-PCR and PCR-RFLP methods, 15% of random samples were re-analyzed by DNA sequencing method (ABI3730xl DNA Analyzer, Applied Biosystems, Foster City, CA).
Statistical analyses
The chi-squared (χ 2 ) test was utilized to assess the Hardy-Weinberg equilibrium (HWE) in allele and genotype distribution, and general characteristics between OS patients and cancer-free controls. The odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated by unconditional logistic regression and utilized to evaluate the potential associations between MDM2 genetic variants and OS risk. All statistical analyses were analyzed by the Statistical Package for Social Sciences software (SPSS, Windows version release 15.0; SPSS Inc.; Chicago, IL, USA). P-values less than 0.05 were considerate as significant level.
Results
General characteristics of subjects
In this case-control study, we enrolled 846 Chinese Han subjects. Table 1 shows the general characteristics of OS patients and cancer-free controls. Our data indicate that there are no significant differences between OS patients and cancer-free controls with regarded to gender, sex, tumor location and metastasis.
Identification of MDM2 genetic variants
Two MDM2 genetic variants (c.44C>T and c.1002T>C) were confirmed through CRS-PCR, PCR-RFLP and DNA sequencing methods. As for c.44C>T, DNA sequence analyses indicate that this genetic variant is a non-synonymous mutation, which causes by C to T mutations in exon2 of the human MDM2 gene. This mutation has result into the proline (Pro) to leucine (Leu) amino acid replacement (p.Pro15Leu, reference sequences GenBank IDs: NG_016708.1, NM_002392.4 and NP_002383.2). The AvaII restriction enzyme was selected to digest the PCR amplified products of c.44C>T, and three genotypes were detected consisted of CC genotype (218 bp), CT genotype (218,197 and 21bp) and TT genotype (197 and 21bp, Table 2 ). As for c.1002T>C, DNA sequence analyses suggest that this genetic variant is a synonymous mutation, which causes by T to C mutations in exon11 of the human MDM2 gene (p. asparagine (Asn) 334Asn, reference sequences GenBank IDs: NG_016708.1, NM_002392.4 and NP_002383.2). The PCR amplified products of c.1002T>C were digested by TspEI restriction enzyme and three genotypes were found, TT genotype (243 bp), TC genotype (243,157 and 86 bp) and CC genotype (157 and 86 bp, Table 2 ).
Genotype and allele frequencies
The genotype and allele frequencies of c.44C>T and c.1002T>C genetic variants in MDM2 gene are performed in Table 3 . The C allele and CC genotype frequencies of c.44C>T and T allele and TT genotype frequencies of c.1002T>C were maximums in OS patients and cancer-free controls. As for c.44C>T, we found significantly differences between the allele frequencies of OS patients (C, 64.34%; T, 35.66%) and those of cancer-free controls (C, 71.00%; T, 29.00%, χ 2 = 8.5822, p = 0.0034), and the genotype frequencies in OS patients were statistically significant different from those of cancer-free controls (χ 2 = 13.6661, p = 0.0011, Table 3 ). As for c.1002T>C, the allele frequencies of OS patients (T, 69.64%; C, 30.36%) were statistically significantly different from healthy controls (T, 74.36%; C, 25.64%, χ 2 = 4.6841, p = 0.0304). The genotype frequencies of OS patients were not consistent with cancer-free controls, the differences being statistically significant (χ 2 = 10.4809, p = 0.0053, Table 3 ). The observed genotype frequencies of c.44C>T and c.1002T>C genetic variants
Discussion
OS is a primary bone tumor and causes from complex interactions between environmental factors and genetic factors. Recently, there are several genetic variants in MDM2 gene have been reported the potential association with OS susceptibility, most of these studies were focused on the rs2279744 (T309G) and rs1690916 genetic variants [16] [17] [18] [19] The chi-squared (χ 2 ) test was utilized to assess the Hardy-Weinberg equilibrium (HWE) in allele and genotype distribution, and general characteristics between OS patients and cancer-free controls. p = 0.008-0.02). The MDM2 T309G polymorphism was marginally non-significantly associated with an increased risk of OS (OR = 1.31, 95% CI 0.97-1.77, p = 0.07). Mirabello and his colleagues indicated that MDM2 gene was found to be significantly associated with OS (p = 0.016), but not after correction for multiple tests [17] . Naumov et al., reported that the allele A of MDM2 rs1690916 polymorphism decreased the disease risk and it could be regarded as protective factor (OR = 0.39, 95% CI 0.19-0.78). These findings confirmed that the MDM2 gene was involved in bone tumor development [19] . Cai conducted a meta-analysis to systematically examine the association between these functional SNPs and sarcoma risk. Compared to TT genotype, carriers of TG and GG genotypes showed a 34% increased risk to develop sarcomas. Results from this meta-analysis indicate that the functional MDM2 T309G genetic variant may play a more important role in carcinogenesis of sarcoma including OS [18] . In the present study, we demonstrate that the c.44C>T and c.1002T>C genetic variants in MDM2 gene are statistically significant correlated with the susceptibility to OS through association analysis in 415 OS patients and 431 cancer-free controls. We found significant differences in allele and genotype frequencies between OS patients and cancer-free controls (All p-values < 0.05, Table 3 ). As for c.44C>T, comparing with CC genotype and CT/CC carriers, the TT genotype was statistically associated with the increased risk of OS (p-values < 0.05). As for c.1002T>C, comparing with TT genotype and TC/TT carriers, the CC genotype was statistically associated with the increased risk of OS (p-values < 0.05). Our data indicate that the T allele and TT genotype of c.44C>T and C allele and CC genotype of c.1002T>C are increased risk factors for the susceptibility to OS in Chinese Han population (Table 4) . Up to date, this is the first report about the potential association of c.44C>T and c.1002T>C genetic variants in MDM2 gene with OS susceptibility. Evidence from this study indicates that MDM2 genetic variants could be utilized as molecular biomarkers for assessing OS susceptibility. Our findings add to the growing literatures that suggest that the association between MDM2 genetic variants and OS susceptibility is complex and incompletely understood. Future functional studies on different ethnic populations are essential to confirm these findings and to elucidate the underling molecular mechanism of genetic influence on the pathogenesis of OS.
